V0132164
EPISERAS
:
Orðmerki:
1755416:
Skráð:
29.08.2023:
15.12.2024:
15.2.2025:
15.2.2025
:
NEURAXPHARM PHARMACEUTICALS, S.L.:
Avenida Barcelona, 69, E-08970 Sant Joan Despi (Barcelona), ES
:
018844566:
6.3.2023:
EUIPO
- 9
Application for mobiles developed using artificial intelligence to determine the risk of epileptic seizures in real time; application for mobiles for the prediction, data management and monitoring of epilepsy; software and applications for mobile devices in the medicine sector, specifically for epileptic seizures; software as a medical device, downloadable; assistive software for the prediction and monitoring of epilepsy; artificial intelligence software for health assistance with epileptic seizures; product engineering software; intelligent character recognition [ICR] software; software for brain stimulus recognition; software for application development; sensory software; scientific, research, measuring, detecting, testing apparatus and instruments; sound, image or data recording, transmission, reproduction or processing apparatus and instruments; recorded or downloadable media, digital recording and storage media.
- 10
Medical device for predicting epileptic seizures in real time; medical devices for the treatment of epilepsy; medical devices for the monitoring, data management and the prediction of epileptic seizures.
- 44
Medical services for the treatment of epilepsy.